Galderma is a pure-play dermatology company, with a leadership position in the self-care segment of the market, with more than 90% of total sales paid by consumers out of pocket. Its long-term revenue ...

The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of bortezomib, ...

Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...

The US-EU deal, which includes a 15 per cent tariff on most EU goods, does not yet provide clarity on how it will affect pharmaceuticals. Although medicines were excluded from the deal, they remain ...

(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion ...

ESPN NFL insider Adam Schefter discusses NFL training camp battles, rookie standouts, contract disputes and more.

Business leaders on both sides of the Atlantic breathed a sigh of relief that the U.S. and European Union had averted a bruising trade war.

MapLight Therapeutics has raised a $372.5 million series D round, clearing the biotech to chart a course through phase 2 for ...

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative Vaccines" BOSTON ...